Report Detail

Other Global Biosimilar Testing Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4513028
  • |
  • 18 February, 2023
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and also offer therapeutic options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample.
According to our (Global Info Research) latest study, the global Biosimilar Testing Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biosimilar Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biosimilar Testing Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biosimilar Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biosimilar Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biosimilar Testing Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilar Testing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilar Testing Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories International, Merck, PPD, LAB Holdings and Eurofins Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biosimilar Testing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pharmacokinetic Assay
Tiered Immunogenicity Testing
Others
Market segment by Application
Hospitals
Pharmaceutical Companies
Others
Market segment by players, this report covers
Charles River Laboratories International
Merck
PPD
LAB Holdings
Eurofins Scientific
Intertek
SGS
Profacgen
Antibody Analytics
Kymos Pharma Services
Medicilon
Pacific BioLabs
Sartorius
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilar Testing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Testing Service, with revenue, gross margin and global market share of Biosimilar Testing Service from 2018 to 2023.
Chapter 3, the Biosimilar Testing Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biosimilar Testing Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Testing Service.
Chapter 13, to describe Biosimilar Testing Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Biosimilar Testing Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biosimilar Testing Service by Type
    • 1.3.1 Overview: Global Biosimilar Testing Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Biosimilar Testing Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Pharmacokinetic Assay
    • 1.3.4 Tiered Immunogenicity Testing
    • 1.3.5 Others
  • 1.4 Global Biosimilar Testing Service Market by Application
    • 1.4.1 Overview: Global Biosimilar Testing Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Pharmaceutical Companies
    • 1.4.4 Others
  • 1.5 Global Biosimilar Testing Service Market Size & Forecast
  • 1.6 Global Biosimilar Testing Service Market Size and Forecast by Region
    • 1.6.1 Global Biosimilar Testing Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Biosimilar Testing Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Biosimilar Testing Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Biosimilar Testing Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Biosimilar Testing Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Biosimilar Testing Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Biosimilar Testing Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Charles River Laboratories International
    • 2.1.1 Charles River Laboratories International Details
    • 2.1.2 Charles River Laboratories International Major Business
    • 2.1.3 Charles River Laboratories International Biosimilar Testing Service Product and Solutions
    • 2.1.4 Charles River Laboratories International Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Charles River Laboratories International Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Biosimilar Testing Service Product and Solutions
    • 2.2.4 Merck Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 PPD
    • 2.3.1 PPD Details
    • 2.3.2 PPD Major Business
    • 2.3.3 PPD Biosimilar Testing Service Product and Solutions
    • 2.3.4 PPD Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 PPD Recent Developments and Future Plans
  • 2.4 LAB Holdings
    • 2.4.1 LAB Holdings Details
    • 2.4.2 LAB Holdings Major Business
    • 2.4.3 LAB Holdings Biosimilar Testing Service Product and Solutions
    • 2.4.4 LAB Holdings Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 LAB Holdings Recent Developments and Future Plans
  • 2.5 Eurofins Scientific
    • 2.5.1 Eurofins Scientific Details
    • 2.5.2 Eurofins Scientific Major Business
    • 2.5.3 Eurofins Scientific Biosimilar Testing Service Product and Solutions
    • 2.5.4 Eurofins Scientific Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.6 Intertek
    • 2.6.1 Intertek Details
    • 2.6.2 Intertek Major Business
    • 2.6.3 Intertek Biosimilar Testing Service Product and Solutions
    • 2.6.4 Intertek Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Intertek Recent Developments and Future Plans
  • 2.7 SGS
    • 2.7.1 SGS Details
    • 2.7.2 SGS Major Business
    • 2.7.3 SGS Biosimilar Testing Service Product and Solutions
    • 2.7.4 SGS Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 SGS Recent Developments and Future Plans
  • 2.8 Profacgen
    • 2.8.1 Profacgen Details
    • 2.8.2 Profacgen Major Business
    • 2.8.3 Profacgen Biosimilar Testing Service Product and Solutions
    • 2.8.4 Profacgen Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Profacgen Recent Developments and Future Plans
  • 2.9 Antibody Analytics
    • 2.9.1 Antibody Analytics Details
    • 2.9.2 Antibody Analytics Major Business
    • 2.9.3 Antibody Analytics Biosimilar Testing Service Product and Solutions
    • 2.9.4 Antibody Analytics Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Antibody Analytics Recent Developments and Future Plans
  • 2.10 Kymos Pharma Services
    • 2.10.1 Kymos Pharma Services Details
    • 2.10.2 Kymos Pharma Services Major Business
    • 2.10.3 Kymos Pharma Services Biosimilar Testing Service Product and Solutions
    • 2.10.4 Kymos Pharma Services Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Kymos Pharma Services Recent Developments and Future Plans
  • 2.11 Medicilon
    • 2.11.1 Medicilon Details
    • 2.11.2 Medicilon Major Business
    • 2.11.3 Medicilon Biosimilar Testing Service Product and Solutions
    • 2.11.4 Medicilon Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Medicilon Recent Developments and Future Plans
  • 2.12 Pacific BioLabs
    • 2.12.1 Pacific BioLabs Details
    • 2.12.2 Pacific BioLabs Major Business
    • 2.12.3 Pacific BioLabs Biosimilar Testing Service Product and Solutions
    • 2.12.4 Pacific BioLabs Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Pacific BioLabs Recent Developments and Future Plans
  • 2.13 Sartorius
    • 2.13.1 Sartorius Details
    • 2.13.2 Sartorius Major Business
    • 2.13.3 Sartorius Biosimilar Testing Service Product and Solutions
    • 2.13.4 Sartorius Biosimilar Testing Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Sartorius Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biosimilar Testing Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Biosimilar Testing Service by Company Revenue
    • 3.2.2 Top 3 Biosimilar Testing Service Players Market Share in 2022
    • 3.2.3 Top 6 Biosimilar Testing Service Players Market Share in 2022
  • 3.3 Biosimilar Testing Service Market: Overall Company Footprint Analysis
    • 3.3.1 Biosimilar Testing Service Market: Region Footprint
    • 3.3.2 Biosimilar Testing Service Market: Company Product Type Footprint
    • 3.3.3 Biosimilar Testing Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biosimilar Testing Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Biosimilar Testing Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Biosimilar Testing Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Biosimilar Testing Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Biosimilar Testing Service Consumption Value by Type (2018-2029)
  • 6.2 North America Biosimilar Testing Service Consumption Value by Application (2018-2029)
  • 6.3 North America Biosimilar Testing Service Market Size by Country
    • 6.3.1 North America Biosimilar Testing Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Biosimilar Testing Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Biosimilar Testing Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Biosimilar Testing Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Biosimilar Testing Service Market Size by Country
    • 7.3.1 Europe Biosimilar Testing Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Biosimilar Testing Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biosimilar Testing Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Biosimilar Testing Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Biosimilar Testing Service Market Size by Region
    • 8.3.1 Asia-Pacific Biosimilar Testing Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Biosimilar Testing Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Biosimilar Testing Service Consumption Value by Type (2018-2029)
  • 9.2 South America Biosimilar Testing Service Consumption Value by Application (2018-2029)
  • 9.3 South America Biosimilar Testing Service Market Size by Country
    • 9.3.1 South America Biosimilar Testing Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Biosimilar Testing Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biosimilar Testing Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Biosimilar Testing Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Biosimilar Testing Service Market Size by Country
    • 10.3.1 Middle East & Africa Biosimilar Testing Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Biosimilar Testing Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Biosimilar Testing Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Biosimilar Testing Service Market Drivers
  • 11.2 Biosimilar Testing Service Market Restraints
  • 11.3 Biosimilar Testing Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Biosimilar Testing Service Industry Chain
  • 12.2 Biosimilar Testing Service Upstream Analysis
  • 12.3 Biosimilar Testing Service Midstream Analysis
  • 12.4 Biosimilar Testing Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biosimilar Testing Service. Industry analysis & Market Report on Biosimilar Testing Service is a syndicated market report, published as Global Biosimilar Testing Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Biosimilar Testing Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,752.68
    4,129.02
    5,505.36
    3,208.56
    4,812.84
    6,417.12
    540,444.00
    810,666.00
    1,080,888.00
    290,580.00
    435,870.00
    581,160.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report